Several human melanoma cell lines produced tissue-type plasminogen activator (t-PA), as detected by zymography and immunocapture assay of culture media and cell lysates. Urokinase (u-PA) was found at only <11% the level of t-PA. Acid eluates of the cell surface indicated that the melanoma cells had t-PA bound on their surface, but no u-PA, and also had a very low capacity to bind exogenous u-PA. After incubation of the melanoma cells with 10% plasminogen-depleted fetal calf serum and human plasminogen, bound plasmin activity could be eluted from the cell surface with tranexamic acid, an analogue of lysine. This indicated that plasminogen was activated on the cell surface. The cellsurface plasmin formation was inhibited by an anticatalytic monoclonal antibody to human t-PA, and not by an anti-catalytic antibody to u-PA. The melanoma cells also synthesized and secreted a2-macroglobulin (a2M), as shown by a2M-specific mRNA in Northern blotting and detection of a2M protein in conditioned cell culture media. The media were found to inhibit u-PA but not t-PA. This inhibition was related to their a2M content, and immunoabsorption of a2M removed the inhibitory activity.
Introduction
Increased production and secretion of plasminogen-activating enzymes has been observed to be a close correlate of the malignant phenotype. Two classes of these serine proteases are recognized, which are distinguishable by their immunological and physicochemical properties, and which have been shown to be the products of different genes (Dan0 et al., 1985) . The tissuetype plasminogen activator (t-PA) of 70 kDa is the main activator involved in fibrinolysis, where its interaction with fibrin and the surface of endothelial cells and platelets (Suenson and Petersen, 1986; Hajjar et aL, 1987; Barnathan et al., 1988; Deguchi and Shirakawa, 1988) favors intravascular plasminogen activation, even in the presence of specific plasminogen activator inhibitors (Hajjar et al., 1987; Leung et al., 1987) . The other activator, urokinase (u-PA), of 52 kDa, is associated with several normal physiological events of tissue degradation or remodeling (Dan0 et al., 1985) , but it is also most clearly increased in malignant tissues, where it is strongly implicated in facilitating invasive mechanisms of tumor spread (Mignatti et al., 1986; Ossowski, 1988; Janicke et al., 1989) .
Melanoma and neuroblastoma cells appear to be exceptional cases, producing mostly t-PA in vitro (Rijken and Collen, 1981; Neuman et al., 1989) and only small amounts of u-PA. In vivo, melanomas exhibit a highly invasive phenotype (Sugarbaker, 1981) , and this therefore raises the question whether an excess of t-PA can serve a similar function to u-PA in promoting proteolytic mechanisms of tissue destruction.
Plasminogen activator (PA) expression depends not only on the rates of synthesis and release of PA proteins and their activation but also on the presence of factors that inhibit or stimulate the PAs (Dan0 et al., 1985) . Available evidence indicates that there are at least three types of specific PA inhibitors (PAI) (Collen, 1986; Sprengers and Kluft, 1987) : PAI-1, also known as the endothelial-type PAI; PAI-2, expressed in the placenta and by monocyte/mac-rophages; and PAI-3, identified in human urine and plasma.
Nonspecific PAI include protease nexin 1 and the wide-spectrum protease inhibitor alpha-2-macroglobulin (a2M) present in many body fluids (Ogston et al., 1973; Holmberg et al., 1980; Korninger and Collen, 1981) . a2M is normally found in plasma in relatively high concentrations (Starkey and Barrett, 1977) and is also present in other body fluids (lymph, pleural, and amniotic fluids), indicating a role in control of proteolysis in the extracellular space (Starkey and Barrett, 1977; Cassiman et al., 1980) . However, at least in culture conditions, human embryonic lung fibroblasts , blood monocyte/macrophages (Hovi et al., 1977) , and alveolar macrophages (White et al., 1980) have been shown to synthesize a2M, suggesting that it may have a role at the cellular level.
Production of a2M by human melanoma cell lines, mostly of metastatic origin, represented the first example of a histological class of tumor cells synthesizing this protease inhibitor (Morgan, 1984) . In a previous report, we described purification and characterization of tumor-associated a2M (TA-a2M) (Bizik et aL, 1986) , secreted by cultured human melanoma and sarcoma cells. Rabbit antibodies prepared against this TA-a2M were used in the immunohistochemical study of tissue sections from human malignant melanomas . Differences found in the distribution of the proteinase inhibitor in the biopsies investigated suggested that TA-a2M may play a role in the clonal evolution of human melanomas. These observations on the presence of a2M in tumor mass in vivo led us to study the full-range effects of inhibitory activities of TA-a2M on t-PA and u-PA, respectively.
We now report on the ability of t-PA to bind to melanoma cells and to carry out cell-surface activation of plasminogen to produce functionally active cell-bound plasmin, as has been recently described for u-PA on the surface of fibrosarcoma cells . We find that t-PA is very negligibly inhibited by TAa2M, whereas, on the contrary, u-PA is inhibited very efficiently. Our results suggest that melanoma cells may employ t-PA rather than u-PA to promote cell-surface proteolysis. Results 
PA activators in human melanoma cell cultures
Cell lysates and conditioned culture media were analyzed for u-PA and t-PA activities by the immunocapture method described in Materials and Methods. Under the conditions used, cultures of five melanoma cell lines secreted -1 lU/ml of tissue PA into serum-free culture medium, as shown in Table 1 . In contrast, no u-PA secretion could be detected. Similar results were obtained when cell lysates were analyzed (Table 1) .
Six human melanoma cell lines and two clones derived from the HMB-2 melanoma cell line were also examined by zymography. Samples of serum-free media, harvested from cell cultures at exponential phase of growth, were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then examined by zymography with casein-agarose overlay gels. The species of secreted PA were determined by comparison of the location of lysis zones with the position of co-electrophoresed samples of human u-PA and t-PA standards. The molecular mass of enzymes producing lysis zones were estimated according to marker proteins in the fixed and stained polyacrylamide gel. When viewed under dark-field illumination with the polyacrylamide slab in situ, the bands of caseinolysis in each sample of conditioned media corresponded exactly with the band observed for t-PA. This is illustrated in Figure 1 . Extremely high secretion of t-PA by Bowes melanoma cell line has previously been documented elsewhere (Rijken and Collen, 1981) . Aliquots of the same conditioned media were tested in a similar way for their capacity to inhibit u-PA (Figure 2 ). Conditioned medium from the Bowes cell line did not inhibit u-PA; media of all other cell lines inhibited u-PA, and much more strongly than t-PA. The M3Dau cell line appeared, in repeated experiments, to secrete the most inhibitor of u-PA of all cell lines studied.
Cell-surface localization of t-PA We used acid elution and microplate immunocapture assay to investigate whether cultured human melanoma cells have PAs bound on their surface. It should be noted that the term "cell bound," used in the present report for bound PA and plasmin, may include enzyme bound to pericellular matrix or substratum. The cultures were rinsed seven times with serum-free medium, and endogenous cell-bound PAs were released from the cell surface with glycine-HCI buffer, pH 3. The buffer was rapidly neutralized and the eluates tested for their activity by the immunocapture method. As shown in Table 2 , t-PA was recovered from all cell lines; the highest t-PA activity was detected in the eluates of the cell lines HMB-2 and M3Dau. No u-PA activity was detected ( Table 2) Figure 2. The PAI content in conditioned media of the melanoma cell lines. Wells of microtests were precoated with goat anti-human u-PA (A) or anti-human t-PA antibodies (B). Unbound antibodies were washed out, and wells were filled with human u-PA or t-PA or t-PA solution. After intensive washing, serum-free conditioned media, estimated and adjusted to the same cell number for each cell line in starting aliquot or plasma a2M (2.5 mg/ml), were serially diluted across the plate. The plates were washed, and then each well was incubated with human plasminogen and the plasmin activity measured by assay of thioesterase activity.
ber of cells , including human tumor cells (Stoppelli et al., 1986) . In most u-PA-producing cells, the receptors are at least partly occupied by the endogenously produced enzyme, but in some cells the receptor is synthesized in the absence of u-PA production (Blasi, 1988) . To investigate whether our human melanoma cell lines possess binding sites for u-PA, we incubated monolayer cultures with 10 lU/mi of exogenous u-PA. After incubation, washing, and acid elution, the activity of eluates was analyzed by microplate immunocapture assay. The results are summarized in Table 3 . As shown, the recovery of bound u-PA activity detected in the eluates of human melanoma cell lines was very low, whereas there was a considerable amount of activity in similar eluates of RD human rhabdomyosarcoma cells after incubation with exogenous u-PA. The amount of u-PA bound by melanoma cells was insignificant in terms of its inability to produce bound plasmin (see Table 4 ). These results indicate that functional binding sites for u-PA are either poorly expressed or absent on the surface of the above human melanoma cell lines. M-2 c. 1 (Figure 3 ).
To test whether the cell-surface plasmin might have been either derived from preformed plasmin, added as a trace contaminant with the plasminogen preparations, or derived from plasmin formed in the medium and subsequently bound to the cells, we added plasmin to the culture medium of HMB-2 cells. As shown in Figure 4 , virtually no plasmin activity was detected on the cell surface when the medium contained 100% FCS. Plasmin added to the serum medium did not reach the cell surface, or at least its activity was abolished by the serum protease inhibitors. There was considerable dose-dependent binding of plasmin in the absence of serum. These findings indicate that the observed cell-bound plasmin activity is formed by activation of plasminogen on the surface of HMB-2 melanoma cells and could not have been taken up from the medium.
Inhibition of formation of bound plasmin on HMB-2 cells in serum culture To confirm that t-PA was responsible for the cell surface plasminogen activation, the cells were incubated with plasminogen in the presence of anti-catalytic monoclonal antibodies to human t-PA. The results, in Table 4 , show that inhibition of the enzymatic activity of t-PA resulted in a strong reduction in plasmin activity on the cell surface, whereas incubation with an anti-catalytic monoclonal antibody to human u-PA only slightly decreased the amount of plasmin activity. Bound plasmin activity was also rapidly reduced when cells were incubated with aprotinin (Table 4) .
Expression of a1IM-specific mRNAs and production of mature protein in melanoma cell lines We have previously reported on a2M production by human melanoma cells (Bizik et al., 1986 (Bizik et al., , 1989 ). Now we analyzed the a2M expression in more detail. Northern blot hybridization analysis of equal amounts of poly(A)+mRNA isolated from the analyzed cell cultures was performed with a human a2M cDNA. As can be seen in Figure 5 , there is a striking variation in the expression of a2M mRNAs. Four of the six melanoma cell lines M3Dau, M1Do, M4Beu, HMB-2 and both HMB-2 cell clones contained significant amounts of 4.6 kb a2M-specific transcript. To determine whether the a2M mRNAs found in melanoma cells are translated to produce mature a2M, we labeled the cell lines with
[35S]methionine and analyzed the culture media by SDS-PAGE. The results are presented in Figure 6 . In previous studies we have shown that the polypeptide band in the region of molecular mass 180 kDa is a2M. There were similar relative intensities of a2M bands in the autoradiogram corresponding to those detected in the Northern blot for individual cell cultures.
Inhibition activity of conditioned media after removal of TA-a2M Samples of conditioned media after immunoabsorption with rabbit anti-TA-a2M coupled to Protein A-Sepharose CL-4B were analyzed for the residual inhibitory activity to u-PA. As can be seen in Table 5 , after elimination of TA-a2M from the tested samples, the values of inhibition were similar or identical with inhibitory activity present in conditioned medium of Bowes cells. This experiment and those above showed that TA-a2M accounted for the majority of PAI activity secreted by human melanoma cells and that this is specific for u-PA.
Discussion
The results obtained in this study provide evidence for the presence of bound t-PA on the surface of human melanoma cells and for its ability to function in producing bound, functionally active plasmin. Thus, active t-PA, not u-PA, was recovered in acid eluates of melanoma cells, and insignificant binding of exogenous u-PA could be demonstrated. On addition of plasminogen, bound active plasmin was formed on the cells, and this process was sensitive to inhibition by antibodies to t-PA and not antibodies to u-PA.
Binding of t-PA has been documented previously for both endothelial cells (Hajjar et aL, 1987; Barnathan et al., 1988) and human fibroblasts (Hoal et al., 1983) . However, clear characterization of a specific receptor protein, as in the case of u-PA (Nielsen et al., 1988) , has not been accomplished. In this study, we showed that t-PA could be recovered in acid eluates of thoroughly washed melanoma cells, providing some evidence that a high-affinity binding site exists. The putative site also exhibited specificity in that exogenous u-PA did not bind.
Because we were able to demonstrate t-PAdependent formation of bound plasmin on serum-cultured cells, we propose that human melanoma cells may employ a t-PA system to produce surface-localized proteolysis instead of u-PA. This possibility has precedent in the process of ovulation in rodents, where t-PA has been shown to be triggered on resumption of meiotic maturation (Huarte et al., 1985) . t-PAdependent proteolysis was observed around live secondary oocytes, demonstrating a possible role in tissue destruction. Elevated levels of t-PA have also been found in superficial keratinizing cells of psoriatic skin (Gr0ndahl-Hansen et al., 1987) , a condition that is also associated with tissue destruction.
As yet, we can only speculate why t-PA may be employed in certain tissues in preference to u-PA. As two conditions of the skin, viz., melanoma and psoriasis, both appear to involve t-PA, this could indicate local conditions that favor t-PA activity over u-PA activity. Of particular relevance may be our earlier finding of a2M in human melanomas , which can inhibit u-PA (Straight et al., 1985) (1986) found that only 1 out of 7 cell lines studied was a u-PA producer. Consistently, Wagner and Binder (1986) screened a panel of 24 melanoma cell cultures and found that 22 cell lines secreted predominantly t-PA; only 4 cell lines also produced u-PA. In our study also, a marked characteristic of the melanoma cell lines was that the PA secreted was almost entirely of the tissue type. The Bowes cell line, included in our study, is in fact widely used as a source material for the purification of t-PA (Rijken and Collen, 1981) .
Thus, our findings strongly suggest that melanoma cells in vitro are able to form active plasmin on their surface by the activation of plasminogen with surface-bound t-PA. This proteolytic system occurs in the presence of concomitant secretion of TA-a2M, which, we show, does not regulate plasminogen activation by t-PA. The TA-a2M may, however, inhibit u-PA in vivo if this enzyme is produced by tumor stroma. The significance of such a t-PA system in an invasive human tumor, and the underlying reason for its use of t-PA rather than u-PA, awaits further investigation.
Materials and methods

Cell cultures
The human melanoma cell line HMB-2 was established from a lymph node metastasis and was kindly provided by Dr. J. Svec, Cancer Research Institute, Bratislava, Czechoslovakia (Siracjky et al., 1982; Svec et al., 1988) . The parental HMB-2 cell line and clones 15 and 33, also used in this study, have been described in detail (Bizik etal., 1989) by Dr. J. F. Dor6, Centre Leon B6rard, Lyon, France (Jakubovich et al., 1985) . The human RD rhabdomyosarcoma cell line (CCL 136) was obtained from the American type Culture Collection, Rockville, MD. All these cell lines were monitored for mycoplasma contamination and were found to be negative. The cultures were grown in Eagle's minimal essential medium (MEM), supplemented with 10% FCS and antibiotics; were harvested by brief exposure to 0.25% trypsin/ 0.02% EDTA; and were subcultured weekly. After reaching confluence, cells were rinsed three times with serum-free MEM and then changed to either serum-free medium or medium containing 100% heat-inactivated and plasminogendepleted (i.e., absorbed with lysine-Sepharose; Pharmacia Fine Chemicals, Uppsala, Sweden) FCS, as indicated in the experiments.
Preparations of conditioned media and cell lysates
After 3 d of cultivation in MEM supplemented with 10% FCS, the cells were washed three times with serum-free medium and incubated with fresh medium for 2 h. This medium was discarded and replaced by fresh medium. After a further 24-h incubation, the conditioned serum-free medium was harvested and passed through a 0.22-lim pore size nitrocellulose filter (Millipore, Bedford, MA) and then tested for u-PA and t-PA activity. Aliquots of the media were adjusted by addition of serum-free medium so as to represent the same number of cells for each cell line. To prepare cell lysates, we treated 5 x 105 cells with 50 mM glycine pH 7.8, 5 mM iodoacetamide, 5 mM EDTA, 0.5% Triton X-100. After lysis, the samples were centrifuged at 5000 x g for 10 min and supernatants were used for the assays of u-PA and t-PA activity.
u-PA assay
Cell culture supernatants and cell lysates were assayed for u-PA activity by the following modification of an immunocapture method mM NaCI, 0.01 Yo Triton X-100, and 20 Mg/ml poly-D-lysine as a stimulator of enzyme activity (Allen, 1982) . The sensitivity was 0.03 lU/ml. Active t-PA and u-PA bound to the cell layer were recovered for immunocapture assay by acid elution. Each culture well (2 cm2), with -5 x 105 cells, was rinsed with serumfree medium and eluted with 150 Al of 50 mM glycine/HCI pH 3.0 containing 0.10 M NaCI (Stoppelli et al., 1986) , for 5 min at 230C. The eluate was neutralized with 50 Ml of 0.5 M Tris-HCI and tested for activity by immunocapture assay as above. Two-chain t-PA (American Diagnostica; 700 000 lU/mg protein) was used as a standard.
Plasmin assay
Plasmin bound to the cell layer was recovered and assayed as follows. After harvest of culture medium, the cells were rinsed three times with PBS, and then the bound plasmin was specifically eluted with a solution of 1 mM tranexamic acid (Cyklokapron; Kabi Vitrum, Stockholm, Sweden) in the rinsing solution (150 MI/well). Plasmin activity was assayed in 50-Ml samples of eluate by incubation with thioester substrate (Green and Shaw, 1979 ) solution (see above) (200 Mll well) for 3 h at 37°C. An estimate of the amount of active plasmin present was made from calibration curves using human plasmin (Kabi Vitrum) diluted in serum-free medium covering an appropriate range of activity. Tranexamic acid at 1 mM had no effect on the thioesterase activity of plasmin in these assays.
Binding of u-PA on the cell surface Cells were plated on tissue culture multiwell plates with 24 flat-bottom wells (Linbro) in 100/ FCS containing MEM. One day later, cells were rinsed with serum-free medium, and the monolayer cultures (-5 x 105 cells) were incubated with 10 lU/ml u-PA (human u-PA 54 kDa; American Diagnostica; 80 000 lU/mg protein) in serum-free medium. After 2 h incubation at 37°C, cell cultures were rinsed three times with serum-free medium and activator eluted with 150 Ml of 50 mM glycine-HCI pH 3 containing 0.1 M NaCI. After 5 min the eluate was collected, neutralized, and tested for activity by the use of immunocapture assay, as above.
Inhibition of PA activity by monoclonal antibodies
Monolayer cultures of 5 x 105 melanoma cells growing in MEM containing 10%o heat-inactivated and plasminogendepleted FCS were incubated with 1) native human plasminogen (40 Mg/ml); 2) plasminogen and anti-catalytic murine monoclonal IgG antibody to human u-PA (5 Mg/ml; American Diagnostica); 3) plasminogen and anti-catalytic monoclonal antibody to human t-PA (5 Mg/ml; American Diagnostica); and 4) plasminogen and aprotinin (Trasylol, 200 klU/ml; Bayer, Leverkusen, FRG). The cultures were incubated for 3 h at 370C before assay of cell-bound plasmin. The incubation with plasminogen was used as the 1 00%o control for bound plasmin.
RNA hybridization and DNA probe Total cellular RNA was extracted using the urea-LiCI method (Auffray and Rougeon, 1980) , poly(A)+RNA was selected by oligo(dT)-cellulose (Type 77F; Pharmacia, Uppsala, Sweden), electrophoresed in 1 Y/o agarose gels containing 2.2 M formaldehyde, transferred (Towbin et al., 1979) to nitrocellulose (Schleicher & Schuell, Dassel, FRG) , and hybridized to 32P-DNA probes according to established procedures (Sambrook et al., 1989) . When hybridization was completed, the filters were washed under nonstringent (1 x NaCI/citrate, 0.50/o SDS, 650C) and/or stringent (0.1 x NaCI/citrate, 0.50/% SDS, 65°C) conditions. Filters were exposed to Kodak XOmat AR film at -750C. The DNA probe was labeled by nick translation (Sambrook et al., 1989 ) using a nick-translation kit (Amersham, Arlington Heights, IL). The a2M cDNA probe used in this study represented the unfragmented plasmid pa2Ml covering the complete a2M gene (Kan et al., 1985) .
Radiolabeling of cultured cells
The conditioned culture medium from a semiconfluent cell layer was replaced with MEM supplemented with 50/o FCS, and [5S]methionine (1200 mCi/Mumol; Amersham) was added to a final activity of 30 MCi/ml. After 24 h of incubation at 350C, the medium was changed for serum-free medium.
This medium was collected after 18 h and any detached cells were removed by centrifugation (3000 x g for 10 min). The conditioned medium was then filtered through a 0.22-Am-pore-size nitrocellulose filter (Millipore) dialyzed against PBS, lyophilized, and analyzed by SDS-PAGE.
SDS-PAGE
Samples dissolved in 1.25 M Tris-HCI, pH 6.8, containing 40/ SDS, 20% glycerol, 100/ 2-mercaptoethanol and 0.005Yo bromphenol blue were heated for 2 min in boiling water and analyzed by the use of vertical polyacrylamide slab gels with a 3.5% acrylamide spacer gel as described (Laemmli, 1970) . Gel with labeled material was impregnated with 2,5-diphenyloxazole (Bonner and Laskey, 1974) , dried, and placed in contact with Kodak X-Omat AR film at -700C.
Zymography
After electrophoresis in a 9% polyacrylamide slab gel under nonreducing conditions, and without heating the specimen, SDS was removed from the gels with extensive washing on a gyratory shaker for 6 h in PBS with 2.5/o Triton X-100 (Granelli-Piperno and Reich, 1978) , and indicator agarose gel containing casein and plasminogen was placed in contact with the polyacrylamide gel. An agarose gel lacking plasminogen was used as a control, and the gel sandwich was incubated overnight at 37°C in a humidified atmosphere to develop lysis zones.
Immunoabsorption of TA-a2M
Rabbit anti-TA-a2M IgG (Bizik et aL., 1989) was coupled to protein A-Sepharose CL-4B (Pharmacia) as described by Hudson and Hay (1980) . One milliliter of protein A-Sepharose was incubated with the same volume of conditioned media for 3 h at room temperature. After incubation, the samples were centrifuged and supernatants were tested for residual inhibiting activity. The colorimetric assay described above was used to test the activity of conditioned media.
